NeuroTalk Support Groups - Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Ni

NeuroTalk Support Groups (https://www.neurotalk.org/)

- ALS News & Research (https://www.neurotalk.org/als-news-and-research/)

- - Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Ni (https://www.neurotalk.org/als-news-and-research/254811-orphazyme-reports-positive-arimoclomol-data-label-phase-2-3-extension-ni.html)

MuonOne

01-03-2020 01:58 PM

Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Ni

Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C
Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C

Orphazyme continues to have hope for efficacy of arimoclomol in Amyotrophic Lateral Sclerosis . . . :

All times are GMT -5. The time now is 09:31 PM.